146 related articles for article (PubMed ID: 25062675)
1. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease.
McFarland KN; Das S; Sun TT; Leyfer D; Kim MO; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH
J Huntingtons Dis; 2013; 2(3):263-77. PubMed ID: 25062675
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.
McFarland KN; Das S; Sun TT; Leyfer D; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH
PLoS One; 2012; 7(7):e41423. PubMed ID: 22848491
[TBL] [Abstract][Full Text] [Related]
3. The polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease.
Bett JS; Benn CL; Ryu KY; Kopito RR; Bates GP
J Cell Mol Med; 2009 Aug; 13(8B):2645-2657. PubMed ID: 19602042
[TBL] [Abstract][Full Text] [Related]
4. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation.
Kim MO; Chawla P; Overland RP; Xia E; Sadri-Vakili G; Cha JH
J Neurosci; 2008 Apr; 28(15):3947-57. PubMed ID: 18400894
[TBL] [Abstract][Full Text] [Related]
5. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.
Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K
Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504
[TBL] [Abstract][Full Text] [Related]
6. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
Sadri-Vakili G; Bouzou B; Benn CL; Kim MO; Chawla P; Overland RP; Glajch KE; Xia E; Qiu Z; Hersch SM; Clark TW; Yohrling GJ; Cha JH
Hum Mol Genet; 2007 Jun; 16(11):1293-306. PubMed ID: 17409194
[TBL] [Abstract][Full Text] [Related]
7. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes.
Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM
Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide uH2A localization analysis highlights Bmi1-dependent deposition of the mark at repressed genes.
Kallin EM; Cao R; Jothi R; Xia K; Cui K; Zhao K; Zhang Y
PLoS Genet; 2009 Jun; 5(6):e1000506. PubMed ID: 19503595
[TBL] [Abstract][Full Text] [Related]
9. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations.
Crocker SF; Costain WJ; Robertson HA
Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nucleosome dynamics in Huntington's disease.
Stack EC; Del Signore SJ; Luthi-Carter R; Soh BY; Goldstein DR; Matson S; Goodrich S; Markey AL; Cormier K; Hagerty SW; Smith K; Ryu H; Ferrante RJ
Hum Mol Genet; 2007 May; 16(10):1164-75. PubMed ID: 17403718
[TBL] [Abstract][Full Text] [Related]
11. Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice.
McCaw EA; Hu H; Gomez GT; Hebb AL; Kelly ME; Denovan-Wright EM
Eur J Biochem; 2004 Dec; 271(23-24):4909-20. PubMed ID: 15606779
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: Histone modifications in Huntington's disease.
Sadri-Vakili G; Cha JH
Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar lipid differences between R6/1 transgenic mice and humans with Huntington's disease.
Denny CA; Desplats PA; Thomas EA; Seyfried TN
J Neurochem; 2010 Nov; 115(3):748-58. PubMed ID: 20731757
[TBL] [Abstract][Full Text] [Related]
14. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease.
Chen-Plotkin AS; Sadri-Vakili G; Yohrling GJ; Braveman MW; Benn CL; Glajch KE; DiRocco DP; Farrell LA; Krainc D; Gines S; MacDonald ME; Cha JH
Neurobiol Dis; 2006 May; 22(2):233-41. PubMed ID: 16442295
[TBL] [Abstract][Full Text] [Related]
15. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Desplats PA; Kass KE; Gilmartin T; Stanwood GD; Woodward EL; Head SR; Sutcliffe JG; Thomas EA
J Neurochem; 2006 Feb; 96(3):743-57. PubMed ID: 16405510
[TBL] [Abstract][Full Text] [Related]
16. The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease.
Dong X; Tsuji J; Labadorf A; Roussos P; Chen JF; Myers RH; Akbarian S; Weng Z
PLoS One; 2015; 10(12):e0144398. PubMed ID: 26636336
[TBL] [Abstract][Full Text] [Related]
17. Glycolipid and ganglioside metabolism imbalances in Huntington's disease.
Desplats PA; Denny CA; Kass KE; Gilmartin T; Head SR; Sutcliffe JG; Seyfried TN; Thomas EA
Neurobiol Dis; 2007 Sep; 27(3):265-77. PubMed ID: 17600724
[TBL] [Abstract][Full Text] [Related]
18. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
Thomas EA; Coppola G; Desplats PA; Tang B; Soragni E; Burnett R; Gao F; Fitzgerald KM; Borok JF; Herman D; Geschwind DH; Gottesfeld JM
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15564-9. PubMed ID: 18829438
[TBL] [Abstract][Full Text] [Related]
19. Altered enhancer transcription underlies Huntington's disease striatal transcriptional signature.
Le Gras S; Keime C; Anthony A; Lotz C; De Longprez L; Brouillet E; Cassel JC; Boutillier AL; Merienne K
Sci Rep; 2017 Feb; 7():42875. PubMed ID: 28225006
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.
Niewiadomska-Cimicka A; Krzyżosiak A; Ye T; Podleśny-Drabiniok A; Dembélé D; Dollé P; Krężel W
Mol Neurobiol; 2017 Jul; 54(5):3859-3878. PubMed ID: 27405468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
